These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tolerability of multiple administration of intramuscular meloxicam: a comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritis. Ghozlan PR, Bernhardt M, Vélicitat P, Bluhmki E. Br J Rheumatol; 1996 Apr; 35 Suppl 1():51-5. PubMed ID: 8630638 [Abstract] [Full Text] [Related]
4. Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration. Euller-Ziegler L, Vélicitat P, Bluhmki E, Türck D, Scheuerer S, Combe B. Inflamm Res; 2001 Mar; 50 Suppl 1():S5-9. PubMed ID: 11339521 [Abstract] [Full Text] [Related]
10. Comparison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients with acute sciatica. Auvinet B, Ziller R, Appelboom T, Velicitat P. Clin Ther; 1995 Mar; 17(6):1078-98. PubMed ID: 8750399 [Abstract] [Full Text] [Related]
11. Endoscopic comparison of the gastroduodenal safety and the effects on arachidonic acid products between meloxicam and piroxicam in the treatment of osteoarthritis. Chang DM, Young TH, Hsu CT, Kuo SY, Hsieh TC. Clin Rheumatol; 2001 Mar; 20(2):104-13. PubMed ID: 11346221 [Abstract] [Full Text] [Related]
16. A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis. Cheng TT, Lai HM, Chiu CK, Chem YC. Clin Ther; 2004 Mar 21; 26(3):399-406. PubMed ID: 15110132 [Abstract] [Full Text] [Related]